Ruthenium oligonucleotides, targeting HPV16 E6 oncogene, inhibit the growth of cervical cancer cells under illumination by a mechanism involving p53

Ruthenium-based chemotherapeutics: are they ready for prime time?

(2010) Emmanuel S. Antonarakis et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Photo-reactive RuII-oligonucleotide conjugates: influence of an intercalating ligand on the inter- and intra-strand photo-ligation processes

(2010) Stéphane Le Gac et al.   DALTON TRANSACTIONS

Clinical and histological effects of blue light on normal skin

(2010) Marloes M. Kleinpenning et al.   PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE

A Photoreactive Ruthenium(II) Complex Tethered to a Guanine-Containing Oligonucleotide: A Biomolecular Tool that Behaves as a “Seppuku Molecule”

(2009) Stéphane Le Gac et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells

(2009) D Hong et al.   BRITISH JOURNAL OF CANCER

Guidelines for topical photodynamic therapy: update

(2008) C.A. Morton et al.   BRITISH JOURNAL OF DERMATOLOGY

Cellular Uptake, Cytotoxicity, and Metabolic Profiling of Human Cancer Cells Treated with Ruthenium(II) Polypyridyl Complexes [Ru(bpy)2(NN)]Cl2with NN=bpy, phen, dpq, dppz, and dppn

(2008) Ulrich Schatzschneider et al.   ChemMedChem

Oligonucleotide Duplexes with Tethered Photoreactive Ruthenium(II) Complexes: Influence of the Ligands and Their Linker on the Photoinduced Electron Transfer and Crosslinking Processes of the Two Strands

(2008) Stéphanie Deroo et al.   EUROPEAN JOURNAL OF INORGANIC CHEMISTRY

Ru(II) complexes and light: molecular tools for biomolecules

(2008) Leslie Herman et al.   JOURNAL OF PHYSICAL ORGANIC CHEMISTRY